IPO Boutique

Heat Biologics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Heat Biologics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Heat BiologicsHTBX -
NASDAQ
$10.00-$12.00 $10.00 $10.002.5 million7/24/2013
Aegis Capital Corp
Co-Manager(s):
Cantor Fitzgerald
Health Care
Filing(s):

Filed 2013-05-03



Heat Biologics Quote & Chart - Click for current quote - HTBX

About Heat Biologics (adapted from Heat Biologics prospectus):
They are a clinical-stage biopharmaceutical company engaged in the development of novel allogeneic, "off-the-shelf" cellular therapeutic vaccines to combat a wide range of cancers and infectious diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "HTBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved